ELF4 Activators encompass a variety of chemical compounds that facilitate the enhancement of ELF4's functional activity through distinct signaling pathways"ELF4 Activators encompass a variety of chemical compounds that facilitate the enhancement of ELF4's functional activity through distinct signaling pathways and cellular processes. Forskolin, by raising cAMP levels, indirectly promotes ELF4's role in the cell cycle and immune response via PKA-mediated phosphorylation, potentially augmenting its transcriptional activity. Similarly, PMA, as a PKC activator, may enhance ELF4 activity by phosphorylating transcription factors, thus influencing ELF4's regulatory functions in inflammatory responses. Ionomycin, through elevation of intracellular Ca2+ levels, could activate Ca2+-dependent signaling mechanisms, thereby enhancing ELF4's involvement in immune gene regulation and circadian rhythm. Resveratrol, activating SIRT1, may influence ELF4 by deacetylating key transcription factors, which could enhance ELF4's immune cell functionality. Lithium chloride's inhibition of GSK-3β, and Retinoic acid's modulation of RARs, both potentially amplify ELF4's transcriptional activity, impacting differentiation and immune response, whereas Spermidine by triggering autophagy, could promote ELF4's role in cellular stress responses.
Further, the strategic inhibition of signaling kinases by compounds such as SB203580 and U0126 may inadvertently shift cellular signaling to pathways that favor ELF4's transcriptional control over immune and stress response genes. Curcumin, by interacting with NF-κB pathways, and Trichostatin A, by facilitating chromatin decondensation through HDAC inhibition, could each enhance ELF4's access to and activation of its target genes. Lastly, Nicotinamide's inhibition of sirtuins might increase ELF4's transcriptional activity by maintaining an acetylated and active state of this transcription factor. Collectively, these ELF4 Activators, through targeted biochemical interactions, support the enhancement of ELF4-mediated functions, which are integral to proper immune response and possibly circadian rhythm regulation, without necessitating an increase in its expression levels or direct activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate transcription factors including ELF4, potentially enhancing its transcriptional activity in cell cycle regulation and immune responses. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator. Activation of PKC can lead to the phosphorylation of downstream transcription factors, such as ELF4, thus potentially enhancing ELF4’s activity in regulating gene expression linked to inflammatory and immune responses. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular Ca2+ levels, which can activate Ca2+-dependent transcription factors and pathways, potentially increasing ELF4's activity in modulating immune response genes and circadian rhythm. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, which can deacetylate transcription factors and modulate their activity. SIRT1 activation might enhance ELF4's functional activity by modulating its post-translational modifications and transcriptional activity in immune cells. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. Inhibition of p38 may shift the equilibrium of cellular signaling pathways, leading to the preferential activation of alternative pathways that could include ELF4-mediated transcription in immune response regulation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates retinoic acid receptors (RARs) which can heterodimerize with other transcription factors and influence gene expression. This interaction may enhance ELF4-mediated transcriptional activity in differentiation and immune response. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $57.00 $607.00 $176.00 | ||
Spermidine is known to induce autophagy and can modulate transcription through epigenetic mechanisms. Inducing autophagy might enhance ELF4's activity by improving cellular homeostasis and promoting transcriptional responses during stress and immune challenges. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin modulates NF-κB activity, which can interact with various transcription factors. By modulating NF-κB, curcumin could enhance ELF4's transcriptional activity in immune response regulation and potentially in circadian rhythm regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA is an HDAC inhibitor. Inhibition of HDACs results in hyperacetylation of histones, which can lead to an open chromatin state and activation of transcription. TSA may enhance ELF4's transcriptional activity by facilitating access to its target genes. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide is an inhibitor of sirtuins, including SIRT1. Inhibition of SIRT1 may lead to increased acetylation of transcription factors, potentially enhancing ELF4's transcriptional activity through post-translational modifications affecting its function. | ||||||